lafora disease/tyrosine

L'enllaç es desa al porta-retalls

Trieu el tipus d'ordenació

10 resultats

A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2).

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Progressive myoclonus epilepsy of the Lafora type or Lafora disease (EPM2; McKusick no. 254780) is an autosomal recessive disorder characterized by epilepsy, myoclonus, progressive neurological deterioration and glycogen-like intracellular inclusion bodies (Lafora bodies). A gene for EPM2 previously

Molecular characterization of laforin, a dual-specificity protein phosphatase implicated in Lafora disease.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Lafora disease is a progressive myoclonus epilepsy with an early fatal issue. Two genes were identified thus far, the mutations of which cause the disease. The first one, EPM2A, encodes the consensus sequence of a protein tyrosine phosphatase. Its product, laforin, is the object of the present work.

Bioptically demonstrated Lafora disease without EPM2A mutation: a clinical and neurophysiological study of two sisters.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Lafora disease (LD) is an autosomal recessive inherited form of progressive myoclonic epilepsy with dementia and ataxia, usually presenting in the second decade of life and inexorably progressing until death. Neuropathological hallmarks are Lafora bodies, intracytoplasmic inclusions that can be

Laforin is a cell membrane and endoplasmic reticulum-associated protein tyrosine phosphatase.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Lafora disease (LD) is the only progressive myoclonus epilepsy with polyglucosan bodies. Among conditions with polyglucosan bodies, LD is unique for the subcellular location of its polyglucosans in neuronal perikarya and dendrites and not in axons. Here we report that the protein encoded by the

Lafora progressive Myoclonus Epilepsy mutation database-EPM2A and NHLRC1 (EPM2B) genes.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Progressive Myoclonus Epilepsy (PME) of the Lafora type is an autosomal recessive disease, which presents in teenage years with myoclonia and generalized seizures leading to death within a decade of onset. It is characterized by pathognomonic inclusions, Lafora bodies (LB), in neurons and other cell

Loss of function of the cytoplasmic isoform of the protein laforin (EPM2A) causes Lafora progressive myoclonus epilepsy.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Lafora disease is the most severe teenage-onset progressive epilepsy, a unique form of glycogenosis with perikaryal accumulation of an abnormal form of glycogen, and a neurodegenerative disorder exhibiting an unusual generalized organellar disintegration. The disease is caused by mutations of the

Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

The progressive myoclonus epilepsy of Lafora type is an autosomal recessive disorder caused by mutations in the EPM2A gene. EPM2A is predicted to encode a putative tyrosine phosphatase protein, named laforin, whose full sequence has not yet been reported. In order to understand the function of the

Isolation and characterization of mouse homologue for the human epilepsy gene, EPM2A.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Mutations in the novel gene, EPM2A, have been shown recently to cause the progressive myoclonus epilepsy of Lafora type. EPM2A is predicted to encode a putative protein-tyrosine phosphatase but its specific role in normal brain function and in the Lafora disease is not known. As a first step towards

Mutational spectrum of the EPM2A gene in progressive myoclonus epilepsy of Lafora: high degree of allelic heterogeneity and prevalence of deletions.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Progressive myoclonus epilepsy of the Lafora type (Lafora disease) is an autosomal recessive disease characterised by epilepsy, myoclonus, progressive neurological deterioration and the presence of glycogen-like intracellular inclusion bodies (Lafora bodies). We recently cloned the major gene for

The laforin/malin E3-ubiquitin ligase complex ubiquitinates pyruvate kinase M1/M2.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

BACKGROUND Lafora disease (LD, OMIM 254780) is a fatal neurodegenerative disorder produced mainly by mutations in two genes: EPM2A, encoding the dual specificity phosphatase laforin, and EPM2B, encoding the E3-ubiquitin ligase malin. Although it is known that laforin and malin may form a functional

Uneix-te a la nostra
pàgina de Facebook

Herbal & Natural Medicine

La base de dades d’herbes medicinals més completa avalada per la ciència

Funciona en 55 idiomes
Cures a base d'herbes recolzades per la ciència
Reconeixement d’herbes per imatge
Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
Llegiu publicacions científiques relacionades amb la vostra cerca
Cerqueu herbes medicinals pels seus efectes
Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents

Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades